Cambridge Biomedical is positioned to provide support throughout the drug development process, from
preclinical through phase IV trials and post-market commercial testing. We are established experts
in complex and custom biomarker assay development, assay validation, and specimen analysis.
Cambridge Biomedical contributes to your project with a select team of professionals working
directly with your staff to develop, validate, and perform custom assays tailored to your specific needs.
With a co-located CLIA certified, CAP accredited, and GLP/GCLP compliant laboratory, Cambridge Biomedical
combines the quality to meet your standards and the scientific expertise to meet your needs.